Related Experiment Video
Updated: Apr 6, 2026

Production of High-Titer Recombinant Newcastle Disease Virus from Allantoic Fluid
Published on: May 25, 2022
The therapeutic effect of death: Newcastle disease virus and its antitumor potential
Sara Cuadrado-Castano1, Maria T Sanchez-Aparicio1, Adolfo García-Sastre2
1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Abstract:
Programmed cell death is essential to survival of multicellular organisms. Previously restricted to apoptosis, the concept of programmed cell death is now extended to other mechanisms, as programmed necrosis or necroptosis, autophagic cell death, pyroptosis and parthanatos, among others. Viruses have evolved to manipulate and take control over the programmed cell death response, and the infected cell attempts to neutralize viral infections displaying different stress signals and defensive pathways before taking the critical decision of self-destruction. Learning from viruses and their interplay with the host may help us to better understand the complexity of the self-defense death response that when altered might cause disorders as important as cancer. In addition, as the fields of immunotherapy and oncolytic viruses advance as promising novel cancer therapies, the programmed cell death response reemerges as a key point for the success of both therapeutic approaches. In this review we summarize the research of the multimodal cell death response induced by Newcastle disease viruses (NDV), considered nowadays a promising viral oncolytic therapeutic, and how the manipulation of the host programmed cell death response can enhance the NDV antitumor capacity.
Insights
Programmed cell death, including necroptosis and pyroptosis, is crucial for multicellular life. Newcastle disease virus (NDV) research reveals how manipulating host cell death pathways can enhance its cancer-fighting potential.
Area of Science:
- Cell Biology
- Virology
- Immunology
Background:
- Programmed cell death (PCD) encompasses diverse mechanisms beyond apoptosis, including necroptosis, pyroptosis, and autophagic cell death.
- Viruses exploit host PCD pathways, while host cells activate defense mechanisms, including self-destruction, to combat infection.
- Altered PCD contributes to diseases like cancer, and understanding PCD is vital for developing novel therapies.
Purpose of the Study:
- To review the multimodal cell death responses induced by Newcastle disease virus (NDV).
- To explore how manipulating host PCD can enhance the antitumor capacity of NDV as an oncolytic therapy.
Main Methods:
- Literature review focusing on programmed cell death mechanisms.
- Analysis of viral-host interactions in the context of cell death.
- Examination of Newcastle disease virus (NDV) as an oncolytic agent.
Main Results:
- NDV induces a multimodal programmed cell death response in infected cells.
- Viral manipulation of host cell death pathways is a key aspect of NDV infection.
- The interplay between NDV and host PCD influences therapeutic outcomes.
Conclusions:
- Programmed cell death is a complex host defense mechanism manipulated by viruses.
- Newcastle disease virus (NDV) shows promise as an oncolytic therapy by engaging multimodal cell death pathways.
- Targeting host cell death pathways could enhance the efficacy of NDV-based cancer treatments.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

